Safety and tolerability of apomorphine sublingual film and subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's disease

被引:0
|
作者
Rascol, O.
Poewe, W.
Stocchi, F.
Chaudhuri, R.
Kassube, J.
Manzanares, L. Lopez
Leta, V.
Zhang, I.
Bowling, A.
Wu, S.
Pappert, E.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
760
引用
收藏
页码:S348 / S348
页数:1
相关论文
共 50 条
  • [21] Safety of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease
    Isaacson, Stuart
    Dubow, Jordan
    Dzyngel, Bruce
    Bilbault, Thierry
    Giovinazzo, Anthony
    Agro, Albert
    ANNALS OF NEUROLOGY, 2015, 78 : S47 - S47
  • [22] Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's Disease: Impact on Impulse Control Disorders
    Espay, A.
    Markopoulou, K.
    Zhang, I.
    Pappert, E.
    Navia, B.
    MOVEMENT DISORDERS, 2021, 36 : S170 - S171
  • [23] Apomorphine Sublingual Film for On-Demand Treatment of "OFF" Episodes in Patients With Parkinson's Disease: Impact on Dyskinesia
    Klos, K.
    Hui, J.
    Robottom, B.
    Bhargava, P.
    Navia, B.
    MOVEMENT DISORDERS, 2020, 35 : S404 - S404
  • [24] Budget Impact of Apomorphine Sublingual Film for On-Demand Treatment of Patients With Parkinson's Disease and "OFF" Episodes
    Thach, A.
    Kirson, N.
    Zichlin, M.
    Dieye, I.
    Pappert, E.
    Williams, G.
    MOVEMENT DISORDERS, 2020, 35 : S427 - S427
  • [25] Apomorphine for the acute treatment of "off" episodes in Parkinson's disease
    Stacy, Mark
    Silver, Dee
    PARKINSONISM & RELATED DISORDERS, 2008, 14 (02) : 85 - 92
  • [26] IMPACT OF BASELINE FACTORS ON RESPONSE TO APOMORPHINE SUBLINGUAL FILM IN PATIENTS WITH PARKINSON'S DISEASE AND "OFF" EPISODES
    Nicholas, A.
    Singer, C.
    Robottom, B.
    Bhargava, P.
    Navia, B.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E85 - E85
  • [27] A Long-Term Safety, Tolerability, and Efficacy Study of Apomorphine Sublingual Film for On-Demand Treatment of "OFF" Episodes in Patients With Parkinson's Disease: Interim Results
    Factor, S.
    Ondo, W.
    Isaacson, S.
    Bhargava, P.
    Navia, B.
    MOVEMENT DISORDERS, 2020, 35 : S395 - S395
  • [28] Indirect comparison of apomorphine sublingual film and levodopa inhalation powder for Parkinson's disease 'OFF' episodes
    Thach, Andrew
    Zichlin, Miriam L.
    Kirson, Noam
    Yang, Karen
    Gaburo, Katherine
    Pappert, Eric
    Mehta, Darshan
    Williams, G. Rhys
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (04) : 285 - 295
  • [29] Motor Responses to Apomorphine Sublingual Film Compared With Levodopa in Patients With Parkinson's Disease and "OFF" Episodes
    Hui, Jennifer
    Fox, Susan
    Neeson, William
    Bhargava, Parul
    Pappert, Eric
    Blum, David
    Navia, Bradford
    NEUROLOGY, 2020, 94 (15)
  • [30] Open-label titration of apomorphine sublingual film in patients with Parkinson's disease and "OFF" episodes
    Hui, Jennifer S.
    Fox, Susan H.
    Neeson, William
    Bhargava, Parul
    Pappert, Eric
    Blum, David
    Navia, Bradford
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : 110 - 116